Lexicon Pharmaceuticals Inc. Common Stock (LXRX)

About LXRX

Sector

Health Care

Industry

Biotechnology: Pharmaceutical Preparations

Website

www.lexpharma.com/

Fundamentals

Market cap

$1.05B

P/E (trailing)

—

P/E (forward)

—

EPS (trailing)

$-0.07

Dividend yield

—

Beta

1.05

Avg. volume

—

Lexicon Pharmaceuticals Inc. Common Stock Competitors

Chosen by industry and closest market cap.

• LXRX

  Lexicon Pharmaceuticals Inc. Common Stock

  $2.29

  ▼ 1.29%
  Market cap $1.05BP/E —
  $1.03$2.68
• OLMA

  Olema Pharmaceuticals Inc. Common Stock

  $10.28

  ▼ 4.77%
  Market cap $1.03BP/E —
  $5.36$36.26
• GERN

  Geron Corporation Common Stock

  $1.51

  ▼ 1.63%
  Market cap $1.01BP/E —
  $1.04$2.01
• IVA

  Inventiva S.A. American Depository Shares

  $4.71

  ▼ 3.98%
  Market cap $1.10BP/E —
  $2.88$6.2
• JANX

  Janux Therapeutics Inc. Common Stock

  $18.01

  ▼ 4.10%
  Market cap $981.85MP/E —
  $12.12$35.34
• OMER

  Omeros Corporation Common Stock

  $18.59

  ▼ 3.43%
  Market cap $951.74MP/E 14.37
  $3.94$19.65
• CRVS

  Corvus Pharmaceuticals Inc. Common Stock

  $14.15

  ▼ 3.87%
  Market cap $1.17BP/E —
  $5.28$26.95

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

• Lexicon Pharmaceuticals Announces Third $10M Milestone Payment Of 2026 From Novo Nordisk On LX9851 Phase 1 Dosing Milestone
  benzinga · 8/24/2026
• Lexicon Pharmaceuticals Edging Closer To 'Go Time' On Multiple Late-Stage Assets
  SeekingAlpha · 8/19/2026
• Lexicon Pharmaceuticals, Inc. 2026 Q2 - Results - Earnings Call Presentation
  SeekingAlpha · 8/10/2026
• Lexicon Pharmaceuticals (NASDAQ:LXRX) Falls as Q2 Revenue Misses Estimates
  ChartMill · 8/6/2026
• Lexicon Pharmaceuticals, Inc. (LXRX) Q2 2026 Earnings Call Transcript
  SeekingAlpha · 8/6/2026
• Lexicon Pharmaceuticals Q2 EPS $(0.07) Misses $(0.05) Estimate, Sales $692.000K Miss $3.998M Estimate
  Benzinga · 8/6/2026

• Swain Judith L · June 3, 2026 · Option Exercise

  89.3K
• Diane E. Sullivan · June 3, 2026 · Option Exercise

  89.3K
• Cheung Ivan · June 3, 2026 · Option Exercise

  89.3K
• Sam L. Barker · June 3, 2026 · Option Exercise

  89.3K
• Philippe Amouyal · June 3, 2026 · Option Exercise

  89.3K
• SOBECKI CHRISTOPHER J · June 3, 2026 · Option Exercise

  89.3K
• DEBBANE RAYMOND · June 3, 2026 · Option Exercise

  89.3K
• Philippe Amouyal · May 1, 2026 · Grant

  43.5K
• Philippe Amouyal · May 1, 2026 · Grant

  35.7K
• Sam L. Barker · May 1, 2026 · Grant

  43.5K
• Sam L. Barker · May 1, 2026 · Grant

  35.7K
• Cheung Ivan · May 1, 2026 · Grant

  43.5K
• Cheung Ivan · May 1, 2026 · Grant

  35.7K
• Swain Judith L · May 1, 2026 · Grant

  43.5K
• Swain Judith L · May 1, 2026 · Grant

  35.7K

Institutional Ownership

March 31, 2026

Total shares held

323.18M

Total value held

$501.79M

Institutional holders

132